We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New Zealand based soft tissue regeneration company Aroa Biosurgery Limited (Aroa) has gained further validation for Endoform®, its flagship extracellular matrix (ECM), with a new study published in the respected international peer-reviewed journal PLOS ON